These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4644172)

  • 1. Acute exacerbation of ankylosing spondylitis after an iron dextran infusion.
    Cantor RI; Downs GE; Abruzzo JL
    Ann Intern Med; 1972 Dec; 77(6):933-4. PubMed ID: 4644172
    [No Abstract]   [Full Text] [Related]  

  • 2. Dextran antibodies, complement conversion and circulating immune complexes after intravenous iron dextran therapy in dialysed patients.
    Fleming LW; Stewart WK; Parratt D
    Nephrol Dial Transplant; 1992; 7(1):35-9. PubMed ID: 1374865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron dextran in clinical medicine.
    Hamstra RD; Block MH; Schocket AL
    JAMA; 1980 May; 243(17):1726-31. PubMed ID: 6154155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of intravenous iron: administration, efficacy, and safety.
    Auerbach M; Ballard H
    Hematology Am Soc Hematol Educ Program; 2010; 2010():338-47. PubMed ID: 21239816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. REACTIONS TO TOTAL DOSE INTRAVENOUS INFUSION OF IRON DEXTRAN (IMFERON).
    CLAY B; ROSENBERG B; SAMPSON N; SAMUELS SI
    Br Med J; 1965 Jan; 1(5426):29-31. PubMed ID: 14213099
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute oxidative stress following intravenous iron injection in patients on chronic hemodialysis: a comparison of iron-sucrose and iron-dextran.
    Stefánsson BV; Haraldsson B; Nilsson U
    Nephron Clin Pract; 2011; 118(3):c249-56. PubMed ID: 21196770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial dysfunction in ankylosing spondylitis improves after tumor necrosis factor-alpha blockade.
    Syngle A; Vohra K; Sharma A; Kaur L
    Clin Rheumatol; 2010 Jul; 29(7):763-70. PubMed ID: 20204669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an inflammatory synovitis following total-dose infusion of iron-dextran. A case report.
    Brighton SW; de la Harpe AL
    S Afr Med J; 1982 Jul; 62(4):141-2. PubMed ID: 7089806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tendinopathy caused by ciprofloxacin with possible partial rupture of Achilles tendon].
    Boulay I; Farge D; Haddad A; Bourrier P; Chanu B; Rouffy J
    Ann Med Interne (Paris); 1993; 144(7):493-4. PubMed ID: 8141519
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral and parenteral iron.
    Med Lett Drugs Ther; 1969 Mar; 11(5):18-9. PubMed ID: 5813815
    [No Abstract]   [Full Text] [Related]  

  • 11. REACTIONS TO INTRAVENOUS IRON DEXTRAN.
    SEFTEL HC
    Br Med J; 1965 Mar; 1(5435):657. PubMed ID: 14245189
    [No Abstract]   [Full Text] [Related]  

  • 12. Early anti-inflammatory intervention ameliorates axial disease in the proteoglycan-induced spondylitis mouse model of ankylosing spondylitis.
    Tseng HW; Glant TT; Brown MA; Kenna TJ; Thomas GP; Pettit AR
    BMC Musculoskelet Disord; 2017 May; 18(1):228. PubMed ID: 28558827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of anaphylactoid reactions to intravenous iron.
    Gupta A
    Am J Kidney Dis; 2000 Feb; 35(2):360-1. PubMed ID: 10676741
    [No Abstract]   [Full Text] [Related]  

  • 14. [So-called drug fever after imferon injection].
    SCHIERBECK NJ
    Ugeskr Laeger; 1959 Mar; 121(10):380-1. PubMed ID: 13659672
    [No Abstract]   [Full Text] [Related]  

  • 15. [An HLA-B27 negative case of ankylosing spondylitis with acute iridocyclitis].
    Yoshikawa M; Nakamura S; Ohno S
    Nippon Ganka Gakkai Zasshi; 1992 Feb; 96(2):271-5. PubMed ID: 1558026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The determination of serum iron after the intravenous injection of iron-dextran.
    WEBSTER D
    J Clin Pathol; 1960 May; 13(3):246-8. PubMed ID: 13843331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment with intravenous iron and infection in hemodialysis].
    Fernández-Gallego J; Ramos B; López de Novales E
    Nefrologia; 2002; 22(1):89-90. PubMed ID: 11987694
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenetic role of certain trace elements (copper, nickel and manganese) and their diagnostic value in ankylosing spondyloarthritis (Bechterev's disease)].
    Pshetakovskiĭ IL
    Vopr Revm; 1973; 13(2):17-20. PubMed ID: 4772867
    [No Abstract]   [Full Text] [Related]  

  • 19. Elevated serum levels of soluble receptor activator of nuclear factors-kappaB ligand (sRANKL) and reduced bone mineral density in patients with ankylosing spondylitis (AS).
    Kim HR; Lee SH; Kim HY
    Rheumatology (Oxford); 2006 Oct; 45(10):1197-200. PubMed ID: 16567356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis.
    Salahudeen AK; Oliver B; Bower JD; Roberts LJ
    Kidney Int; 2001 Oct; 60(4):1525-31. PubMed ID: 11576368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.